Low-Dose Naltrexone (LDN) and Crohn's Disease: What PubMed Studies Show

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Low-Dose Naltrexone (LDN) and Crohn's Disease: What PubMed Studies Show

PubMed is the primary database of biomedical literature maintained by the National Library of Medicine. This page describes what PubMed-indexed research reveals about Low-Dose Naltrexone (LDN) in the context of Crohn's Disease. This is a research summary — not medical advice. Consult your gastroenterologist.

Volume of Available Research

As of 2026, PubMed contains dozens of relevant publications when searching for "Low-Dose Naltrexone (LDN)" combined with "Crohn's Disease". The current evidence level derived from this literature is: Phase II trials for MS, Crohn's, fibromyalgia; promising but small studies

Types of Studies Available

Given the scientific interest in this combination, the published literature includes a range of study types:

  • In vitro (cell culture) studies: Laboratory investigations of Low-Dose Naltrexone (LDN) effects on Crohn's-relevant cell lines
  • In vivo (animal) studies: Preclinical models examining effects on disease pathways
  • Review articles: Systematic reviews and meta-analyses synthesizing available evidence
  • Clinical studies: Human data from case reports, cohort studies, or clinical trials

How to Search PubMed Yourself

To find the most current and complete literature, use these PubMed search strategies:

  • Basic search: Low-Dose Naltrexone (LDN) Crohn's Disease
  • Advanced search: (Low-Dose Naltrexone (LDN)[Title/Abstract]) AND (Crohn's Disease[Title/Abstract])
  • Filter by article type: Select "Clinical Trial" to focus on human studies
  • Sort by: Most Recent to see latest publications

Interpreting PubMed Results

When reviewing PubMed studies for Low-Dose Naltrexone (LDN) and Crohn's, key considerations include:

  • Study design hierarchy: RCTs > cohort studies > case-control > case reports > animal studies > cell culture
  • Sample size: Small studies (n<50) should be interpreted cautiously
  • Conflict of interest: Check funding sources
  • Replication: Single studies should not change treatment decisions

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

How many PubMed studies exist on Low-Dose Naltrexone (LDN) for Crohn's?

The exact count changes as new research is published. Search pubmed.ncbi.nlm.nih.gov for 'Low-Dose Naltrexone (LDN) AND Crohn's Disease' to get the current count. The evidence level from available literature is: Phase II trials for MS, Crohn's, fibromyalgia; promising but small studies.

Are there PubMed clinical trial results for Low-Dose Naltrexone (LDN) in Crohn's?

To find clinical trial publications: go to PubMed, search 'Low-Dose Naltrexone (LDN) Crohn's', then use the 'Article type' filter to select 'Clinical Trial'. Some clinical data exists for this combination.

Can I access the full text of Low-Dose Naltrexone (LDN) + Crohn's studies for free?

Many NIH-funded studies are available free via PubMed Central (PMC). For paywalled articles, try: the author's institution page, ResearchGate, or emailing the corresponding author directly. Some patients also access papers through their hospital library or university networks.